Patents by Inventor Adeline Hajjar

Adeline Hajjar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOTHERAPEUTIC POTENTIAL OF MODIFIED LIPOOLIGOSACCHARIDES/LIPID A
    Publication number: 20210381015
    Abstract: Embodiments of the disclosure provide for unique lipooligosaccharide/lipid A-based mimetics for use as adjuvants. Methods of generating lipooligosaccharide/lipid A-based mimetics are provided that utilize recombinantly engineered bacteria to produce the mimetics, including, for example, addition of one or more particular enzymes such as acyltransferases, deacylases, phosphatases, or glycosyltransferases.
    Type: Application
    Filed: August 23, 2021
    Publication date: December 9, 2021
    Inventors: Robert K. Ernst, Mark Pelletier, Adeline Hajjar
  • Immunotherapeutic potential of modified lipooligosaccharides/lipid A
    Patent number: 11124815
    Abstract: Embodiments of the disclosure provide for unique lipooligosaccharide/lipid A-based mimetics for use as adjuvants. Methods of generating lipooligosaccharide/lipid A-based mimetics are provided that utilize recombinantly engineered bacteria to produce the mimetics, including, for example, addition of one or more particular enzymes such as acyltransferases, deacylases, phosphatases, or glycosyltransferases.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: September 21, 2021
    Assignees: UNIVERSITY OF MARYLAND, BALTIMORE, UNIVERSITY OF WASHINGTON
    Inventors: Robert K. Ernst, Mark Pelletier, Adeline Hajjar
  • IMMUNOTHERAPEUTIC POTENTIAL OF MODIFIED LIPOOLIGOSACCHARIDES/LIPID A
    Publication number: 20190367959
    Abstract: Embodiments of the disclosure provide for unique lipooligosaccharide/lipid A-based mimetics for use as adjuvants. Methods of generating lipooligosaccharide/lipid A-based mimetics are provided that utilize recombinantly engineered bacteria to produce the mimetics, including, for example, addition of one or more particular enzymes such as acyltransferases, deacylases, phosphatases, or glycosyltransferases.
    Type: Application
    Filed: June 4, 2019
    Publication date: December 5, 2019
    Inventors: Robert K. Ernst, Mark Pelletier, Adeline Hajjar
  • Immunotherapeutic potential of modified lipooligosaccharides/lipid A
    Patent number: 10358667
    Abstract: Embodiments of the disclosure provide for unique lipooligosaccharide/lipid A-based mimetics for use as adjuvants. Methods of generating lipooligosaccharide/lipid A-based mimetics are provided that utilize recombinantly engineered bacteria to produce the mimetics, including, for example, addition of one or more particular enzymes such as acyltransferases, deacylases, phosphatases, or glycosyltransferases.
    Type: Grant
    Filed: March 7, 2014
    Date of Patent: July 23, 2019
    Assignees: University of Maryland, Baltimore, University of Washington through its Center for Commercialization
    Inventors: Robert K. Ernst, Mark Pelletier, Adeline Hajjar
  • IMMUNOTHERAPEUTIC POTENTIAL OF MODIFIED LIPOOLIGOSACCHARIDES/LIPID A
    Publication number: 20160002691
    Abstract: Embodiments of the disclosure provide for unique lipooligosaccharide/lipid A-based mimetics for use as adjuvants. Methods of generating lipooligosaccharide/lipid A-based mimetics are provided that utilize recombinantly engineered bacteria to produce the mimetics, including, for example, addition of one or more particular enzymes such as acyltransferases, deacylases, phosphatases, or glycosyltransferases.
    Type: Application
    Filed: March 7, 2014
    Publication date: January 7, 2016
    Inventors: Robert K. Ernst, Mark Pelletier, Adeline Hajjar